reviewTop 1% cited
MYC oncogenes and human neoplastic disease
Oncogene · 1999 · Vol. 18(19) · pp. 3004–3016
Chadd E. Nesbit✉(Children's Hospital of Pittsburgh)Jean M. Tersak(Children's Hospital of Pittsburgh)Edward V Prochownik(University of Pittsburgh Medical Center)
Cancer-related Molecular PathwaysChronic Lymphocytic Leukemia ResearchUbiquitin and proteasome pathwaysBiologyNeoplastic diseaseDiseaseCarcinogenesisGeneCausationPathogenesisGeneticsCancer researchImmunology
MeSH terms
Cell Transformation, NeoplasticDNA, NeoplasmHumansNeoplasmsTranscriptional ActivationGenes, myc
Funding
- National Institutes of Health
Citations
1,166
FWCI
14.66
field-weighted impact
References
198
Percentile
99%
vs. same field & year
Citations per year
Cited by
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Nature Cell Biology · 2010 · 1,322 citations
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Genes & Development · 2000 · 1,414 citations
References
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
Nature Genetics · 1997 · 2,757 citations
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Molecular and Cellular Biology · 1999 · 1,727 citations
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
Nature Genetics · 1997 · 2,083 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.